UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Core Viewpoint - A class action lawsuit has been filed against Unicycive Therapeutics, Inc. on behalf of shareholders who purchased securities during the specified class period from March 29, 2024, to June 27, 2025 [1] Company Summary - Unicycive Therapeutics, Inc. is identified as a clinical-stage biotechnology company [1] - The lawsuit is being investigated by Rosen Law Firm, a global investor rights law firm [1]